Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
UMG1/CD3ε-bispecific T-cell engager redirects T-cell cytotoxicity against diffuse large B-cell lymphoma.
Caracciolo D, Polerà N, Belmonte B, Conforti F, Signorelli S, Gulino A, Staropoli N, Tuccillo FM, Bonelli P, Juli G, Grillone K, Ascrizzi S, Cirillo M, Migale L, Ballerini A, Pelizon C, Di Martino MT, Tagliaferri P, Riillo C, Tassone P. Caracciolo D, et al. Among authors: signorelli s. Br J Haematol. 2024 Feb;204(2):555-560. doi: 10.1111/bjh.19183. Epub 2023 Nov 14. Br J Haematol. 2024. PMID: 37963444
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas.
Polerà N, Mancuso A, Riillo C, Caracciolo D, Signorelli S, Grillone K, Ascrizzi S, Hokanson CA, Conforti F, Staropoli N, Gervasi L, Di Martino MT, Arbitrio M, Nisticò G, Crea R, Tagliaferri P, Juli G, Tassone P. Polerà N, et al. Among authors: signorelli s. Cancers (Basel). 2023 Mar 8;15(6):1647. doi: 10.3390/cancers15061647. Cancers (Basel). 2023. PMID: 36980534 Free PMC article.
A Pronectin™ AXL-targeted first-in-class bispecific T cell engager (pAXLxCD3ε) for ovarian cancer.
Riillo C, Polerà N, Di Martino MT, Juli G, Hokanson CA, Odineca T, Signorelli S, Grillone K, Ascrizzi S, Mancuso A, Staropoli N, Caparello B, Cerra M, Nisticò G, Tagliaferri P, Crea R, Caracciolo D, Tassone P. Riillo C, et al. Among authors: signorelli s. J Transl Med. 2023 May 4;21(1):301. doi: 10.1186/s12967-023-04101-x. J Transl Med. 2023. PMID: 37143061 Free PMC article.
Determination of Free Proline in Plants.
Sena F, Monza J, Signorelli S. Sena F, et al. Among authors: signorelli s. Methods Mol Biol. 2024;2798:183-194. doi: 10.1007/978-1-0716-3826-2_12. Methods Mol Biol. 2024. PMID: 38587743
A Retrospective Cohort Evaluation of Left Ventricular Remodeling, Perioperative Complications and Outcome in Medium and Large Size Dogs with Patent Ductus Arteriosus after Percutaneous Closure.
Papa M, Scarpellini L, Pradelli D, Zanaboni AM, Mattia A, Boz E, Rossi C, Signorelli S, Forti V, Longobardi M, Pasquinelli B, Gendusa MC, Gamba D, Bussadori CM. Papa M, et al. Among authors: signorelli s. Vet Sci. 2023 Nov 24;10(12):669. doi: 10.3390/vetsci10120669. Vet Sci. 2023. PMID: 38133219 Free PMC article.
The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population.
Dattilo G, Laterra G, Licordari R, Parisi F, Pistelli L, Colarusso L, Zappia L, Vaccaro V, Demurtas E, Allegra M, Crea P, Di Bella G, Signorelli SS, Aspromonte N, Imbalzano E, Correale M. Dattilo G, et al. Among authors: signorelli ss. J Clin Med. 2023 Sep 28;12(19):6247. doi: 10.3390/jcm12196247. J Clin Med. 2023. PMID: 37834892 Free PMC article.
Platelet‑to‑lymphocyte ratio, neutrophil‑to‑lymphocyte ratio and monocyte‑to‑HDL cholesterol ratio as helpful biomarkers for patients hospitalized for deep vein thrombosis.
Selvaggio S, Brugaletta G, Abate A, Musso C, Romano M, Di Raimondo D, Pirera E, Dattilo G, Signorelli SS. Selvaggio S, et al. Among authors: signorelli ss. Int J Mol Med. 2023 Jun;51(6):52. doi: 10.3892/ijmm.2023.5255. Epub 2023 May 11. Int J Mol Med. 2023. PMID: 37165933
272 results